삼성서울병원

Ko En

Hematology-Oncology Lee, Jeeyun M.D

Expertise
Gastric cancer, colorectal cancer, sarcoma, melanoma, others
Treament Schedule 04 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
AM
PM
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical Education

2005 Ph.D. in Medicine Graduate School of Sungkyunkwan University, Korea
2002 Master of Science Graduate School of Sungkyunkwan University, Korea
1999 College of Medicine, Ewha Womans University, Korea

Post-Graduate Training

Fellowship   2004~2005 Clinical Fellowship in Hematology-Oncology, Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Residency   2000~2003 Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Internship   1999~2000 Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Professional Appointments

2022~present Director Precision Oncology Center, Samsung Medical Center
2019~present Director Experimental Therapeutics Development Center, Samsung Medical Center
2019~2022 Member Member of Samsung Future Technology Meeting Committee, Korea
2020~present Professor Department of Intelligence Precision Convergence Engineering, SKKU, Suwon
2020~ Professor Division of Hem/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine
2014~2020 Associate Professor Division of Hem/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine
2010~2014 Assistant Professor Division of Hem/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine
2006~2010 Clinical Assistant Professor Division of Hem/Oncology, Samsung Medical Center
2006~2008 Visiting Scientist Sidney Kimmel Cancer Center, San Diego, CA, USA
2005.07 completed AACR Workshop in Cancer Research: Molecular Biology in Clinical Oncology
2004.08 completed Australia and Asia Pacific Clinical Oncology Research Development Workshop: A Workshop in Effective Clinical Trials Design

Professional Memberships

Present Member American Society of Clinical Oncology
Present Member AACR
Present Member Korean Association of Clinical Oncology

Selected Publications

  • EUR RADIOL 2021 10.1007/s00330-021-08094-3 Prediction of epithelial-to-mesenchymal transition molecular subtype using CT in gastric cancer Cha1, DI; Lee, J; Jeong, WK; Kim, ST; Kim, JH; Hong, JY; Kang, WK; Kim, KM; Kim, SW; Choi, D
    View PubMed
  • NATURE 2021 10.1038/s41586-021-03515-1 ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma Yen1, I; Shanahan, F; Lee, J; Hong, YS; Shin, SJ; Moore, AR; Sudhamsu, J; Chang, MT; Bae, I; Dela Cruz, D; Hunsaker, T; Klijn, C; Liau, NPD; Lin, E; Martin, SE; Modrusan, Z; Piskol, R; Segal, E; Venkatanarayan, A; Ye, X; Yin, JP; Zhang, LX; Kim, JS; Lim, HS; Kim, KP; Kim, YJ; Han, HS; Lee, SJ; Kim, ST; Jung, M; Hong, YH; Noh, YS; Choi, M; Han, O; Nowicka, M; Srinivasan, S; Yan, YB; Kim, TW; Malek, S
    View PubMed
  • CANCERS 2021 10.3390/cancers13102316 Validation of the Combined Biomarker for Prediction of Response to Checkpoint Inhibitor in Patients with Advanced Cancer Kim1, JC; Heo, YJ; Kang, SY; Lee, J; Kim, KM
    View PubMed
  • JAMA ONCOL 2021 10.1001/jamaoncol.2021.0275 Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials Chao1, JS; Fuchs, CS; Shitara, K; Tabernero, J; Muro, K; Van Cutsem, E; Bang, YJ; De Vita, F; Landers, G; Yen, CJ; Chau, I; Elme, A; Lee, J; Ozguroglu, M; Catenacci, D; Yoon, HH; Chen, ER; Adelberg, D; Shih, CS; Shah, SK; Bhagia, P; Wainberg, ZA
    View PubMed
  • J DERMATOL 2021 10.1111/1346-8138.15824 Clinical profile of cutaneous adverse events of immune checkpoint inhibitors in a single tertiary center Park1, JH; Yoon, D; Lee, J; Oh, SJ; Kim, HJ; Lee, JH; Lee, DY
    View PubMed